Wyeth’s Hot Flash: Pristiq “Approvable” Delays Vasomotor Claim At Least A Year

Building a stable of next-generation women's health products is not coming easily to Wyeth. The drug maker received an "approvable" letter July 23 for its Effexor XR follow-on Pristiq for treatment of vasomotor symptoms of menopause, including night sweats and hot flashes